About Cenetron
Cenetron is a Healthcare company based in Austin (United States) founded in 1995 by Dwight DuBois, and was acquired by Versiti in July 2019. Central laboratory services for clinical trials are offered. Cenetron offers products and services including Collection Kit Design, Assay Development, and Regulatory Services. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its competitors include Celgene, Medelis WCCT Global and Syneos Health; 2 of its 3 listed competitors have raised funding.
Company details
Founded in 1995 in Austin, United States, Cenetron operates in the clinical trial sector. Customized specimen collection kits, data management, laboratory reports, and trial site support are provided. End-to-end sample collection solutions are handled, along with complete central laboratory services that encompass protocol review, technology consultation, laboratory testing, and clinical study data management.
- Headquarters Austin, United States
- Founders Dwight DuBois
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cenetron.com
- Social LinkedIn X
- Acquired by Versiti (Jul 2019)
Products & Services of Cenetron
Cenetron offers a comprehensive portfolio of products and services, including Collection Kit Design, Assay Development, and Regulatory Services.
Design and assembly of kits for specimen collection in trials
Development and validation of biomarkers for research purposes
Guidance on regulatory strategies and filings for trials
Investors in Cenetron
Cenetron has secured backing from 1 investor. Prominent investors backing the company include Versiti.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Blood bank | 2012 | versiti.org | Milwaukee, United States |
Investor details for Cenetron
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cenetron
1 people are tracked at Cenetron (1 in leadership).
| Name | Role | Group |
|---|---|---|
Dwight DuBois | Founder & President | Leadership |
Complete people profiles for Cenetron
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cenetron
2 dated milestones of Cenetron across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Cenetron is founded.
- Exit Acquired by Versiti.
Competitors of Cenetron
Cenetron has 3 listed competitors in our database, 2 of them funded. They include Celgene, Medelis WCCT Global and Syneos Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| celgene.com | 1986 | Summit, United States | $45M | 4,891 | Therapies for cancer and inflammatory diseases are developed. | |
| wcct.com | 1998 | Cypress, United States | $17M | 229 | Full-service CRO expertise in influenza and oncology research is offered. | |
| syneoshealth.com | 1984 | Raleigh, United States | 29,395 | CRO clinical development services are provided by Syneos Health. |
Detailed competitors of Cenetron
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Cenetron (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cenetron
Cenetron was founded in 1995.
Cenetron is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Founded in 1995 in Austin, United States, Cenetron operates in the clinical trial sector. Customized specimen collection kits, data management, laboratory reports, and trial site support are provided. End-to-end sample collection solutions are handled, along with complete central laboratory services that encompass protocol review, technology consultation, laboratory testing, and clinical study data management.
Cenetron's top competitors include Syneos Health, Medelis WCCT Global and Celgene.
Cenetron offers Collection Kit Design, Assay Development, and Regulatory Services.
Cenetron has 1 investor. Key investors include Versiti.
Yes. Cenetron was acquired by Versiti in July 2019.